Latest SEC Filings

Celsius Holdings, Inc.Celsius Holdings Reports 10.6% Revenue Growth to $817.9 Million in Latest Quarter

KULICKE & SOFFA INDUSTRIES INCKulicke and Soffa Reports 122.6% Revenue Increase to $330.4 Million in Latest Quarter

FORRESTER RESEARCH, INC.Forrester Research Reports 10% Revenue Decline in Q2 2026

Privia Health Group, Inc.Privia Health Reports 21.4% Revenue Growth to $632.6 Million in Q2 2026

MOLSON COORS BEVERAGE COMolson Coors Reports Decline in Q2 2026 Financial Performance

CG Oncology, Inc.CG Oncology Reports $1.2 Million Revenue in Q2 2026, Net Loss Increases to $79.1 Million

Barinthus Biotherapeutics plc.Barinthus Biotherapeutics Reports Reduced Losses and Strategic Merger Plans for 2026

Playtika Holding Corp.Playtika Reports 5% Revenue Growth to $731.1 Million in Q2 2026

Priority Technology Holdings, Inc.Priority Technology Holdings Reports 9.4% Revenue Growth to $262.3 Million in Q2 2026

Valaris LtdValaris Limited Reports Decline in Revenue and Net Income for Q2 2026

Sonoma Pharmaceuticals, Inc.Sonoma Pharmaceuticals Reports 60% Revenue Growth to $6.4 Million for Q2 2026

AEMETIS, INCAemetis Reports 20% Revenue Growth to $62.7 Million in Q2 2026

MARKETWISE, INC.MarketWise Reports Q2 2026 Financial Results with Revenue Decline and Increased Billings

Praxis Precision Medicines, Inc.Praxis Precision Medicines Reports $176.3 Million Net Loss and Advances Product Pipeline

Oyster Enterprises II Acquisition CorpOyster Enterprises II Acquisition Corp Reports $2.2 Million Net Income for Q2 2026

ACORN ENERGY, INC.Acorn Energy Reports 29% Revenue Decline and 82% Drop in Net Income for First Half of 2026

CRA INTERNATIONAL, INC.CRA International Reports 12.8% Revenue Growth to $210.8 Million for Quarter Ended July 4, 2026

Aurinia Pharmaceuticals Inc.Aurinia Pharmaceuticals Reports 19% Revenue Growth to $83.2 Million in Q2 2026

PATRICK INDUSTRIES INCPatrick Industries Reports Q2 2026 Results: Decline in Net Sales but Increase in Net Income

Aligos Therapeutics, Inc.Aligos Therapeutics Reports $30.6M Revenue and $1.5M Net Loss for Q2 2026

Globalstar, Inc.Globalstar Reports Q2 2026 Revenue Decline to $64.8 Million, Net Loss of $26.5 Million

MBX Biosciences, Inc.MBX Biosciences Reports $37.1 Million Net Loss in Q2 2026, Increases R&D Spending

ECOLAB INC.Ecolab Reports 10% Revenue Growth to $4.415 Billion in Q2 2026

BlackRock TCP Capital Corp.BlackRock TCP Capital Corp. Reports Decrease in Net Investment Income for Q2 2026

Twin Vee PowerCats, Co.Twin Vee PowerCats Reports 34% Decline in Net Sales for Q2 2026